Article Details
Retrieved on: 2024-04-29 20:14:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Currently, monoclonal antibodies targeting immune checkpoint proteins are a mainstay of cancer therapy and cancer drug development.
Article found on: www.digitaljournal.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here